It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The World Health Organization issued a warning last year about insulin pens relabeled and repackaged to look like Ozempic.

Catalent is the main supplier of fill-finish work, which involves filling and packaging syringes and injection pens, for Wegovy. Novo Nordisk will then buy three of Catalent's manufacturing sites ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Novo Nordisk NVO shares have lost 5% in the past three months, which translates to approximately $29 billion in market value, ...

We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...

Novo Nordisk CEO Lars Fruergaard Jørgensen has agreed to testify ... Hurtado Andrade said she also worries about the ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

There are currently no pharmaceutical treatments approved for general obesity in under-12s — as opposed to that found with some rare genetic disorders — said Claudia Fox, a professor from University ...

NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage ...

A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, ...